Sinovac Biotech Ltd
NASDAQ:SVA
Sinovac Biotech Ltd
Net Income (Common)
Sinovac Biotech Ltd
Net Income (Common) Peer Comparison
Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors
Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Sinovac Biotech Ltd
NASDAQ:SVA
|
Net Income (Common)
$107.9m
|
CAGR 3-Years
39%
|
CAGR 5-Years
33%
|
CAGR 10-Years
N/A
|
|
Beigene Ltd
HKEX:6160
|
Net Income (Common)
-¥13.6B
|
CAGR 3-Years
-25%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Innovent Biologics Inc
HKEX:1801
|
Net Income (Common)
-¥1B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
29%
|
CAGR 10-Years
N/A
|
|
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
|
Net Income (Common)
¥1.2B
|
CAGR 3-Years
23%
|
CAGR 5-Years
34%
|
CAGR 10-Years
N/A
|
|
S
|
Shanghai RAAS Blood Products Co Ltd
SZSE:002252
|
Net Income (Common)
¥2.1B
|
CAGR 3-Years
23%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
24%
|
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
|
Net Income (Common)
¥8.5B
|
CAGR 3-Years
40%
|
CAGR 5-Years
47%
|
CAGR 10-Years
45%
|
See Also
What is Sinovac Biotech Ltd's Net Income (Common)?
Net Income (Common)
107.9m
USD
Based on the financial report for Dec 31, 2022, Sinovac Biotech Ltd's Net Income (Common) amounts to 107.9m USD.
What is Sinovac Biotech Ltd's Net Income (Common) growth rate?
Net Income (Common) CAGR 5Y
33%
Over the last year, the Net Income (Common) growth was -99%. The average annual Net Income (Common) growth rates for Sinovac Biotech Ltd have been 39% over the past three years , 33% over the past five years .